Nutragen Pharma Private Limited

Nutragen Pharma Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24232TN2005PTC056577 Incorporated 10 June 2005 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2023
₹2.21 Cr
▲ 9% YoY
Net profit · FY 2023
₹1.34 Lakh
Net margin 0.6%
EBITDA · FY 2023
₹24.16 Lakh
EBITDA margin 10.9%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4.75 Cr
Issued & subscribed
Open charges
₹1.84 Cr
Satisfied ₹1.49 Cr
Company age
21 yrs
Est. 2005
Directors on board
3
As per MCA filings

About Nutragen Pharma Private Limited

Data last updated:

Nutragen Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 June 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2005PTC056577. Its GSTIN is 32AACCN4110B1ZF (Kerala). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.75 Cr. It is led by directors including Sujayababu Jayasankar (Managing Director) and Padmini Sankaran.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door 65 – A First Floor 5th Street Bismillah Nagar Vettuvenkeni, Chennai, Tamil Nadu, India – 600115.

As per the financials filed for FY 2023, the company reported a revenue of ₹2.21 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.34 Lakh (net margin 0.6%) and EBITDA of ₹24.16 Lakh (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.

The company is associated with 1 brand: Nutragen Pharma. As per MCA filings, the company has open charges of ₹1.84 Cr and satisfied charges of ₹1.49 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending.

Nutragen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-12-0016426). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nutragenpharma.in.

Company details

CIN U24232TN2005PTC056577
Registration Number 056577
Incorporation Date 10 June 2005
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-12-0016426

Recognitions & Rankings of Nutragen Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-KL-12-0016426

Contact details

Nutragen Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its website is nutragenpharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Door 65 – A First Floor 5th Street Bismillah Nagar Vettuvenkeni, Chennai, Tamil Nadu, India – 600115
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Nutragen Pharma Private Limited, buy the company report.

Comprehensive company report
Nutragen Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Nutragen Pharma operates one associated brand: Nutragen Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Global contract manufacturing of high-quality pharmaceutical and nutraceutical products.nutragenpharma.in

Business activity

The main business activity of Nutragen Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Nutragen Pharma Private Limited, buy the company report.

Financials of Nutragen Pharma Private Limited

FY 2025 filings available

Nutragen Pharma Private Limited reported revenue of ₹2.21 Cr (up 9% YoY) for FY 2023.

Revenue · FY 2023
₹2.21 Cr ▲ 9%
Net profit · FY 2023
₹1.34 Lakh margin 0.6%
EBITDA · FY 2023
₹24.16 Lakh margin 10.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 7%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 9%
5 years · compounded
▲ 54%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 9% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹2.21 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹24.16 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.34 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin10.9%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nutragen Pharma Private Limited, buy the company report.

Board of directors of Nutragen Pharma Private Limited

Nutragen Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Padmini SankaranDirector16 Jan 200917 Years 9 MonthsCurrent
Sujayababu JayasankarManaging Director10 Jun 200521 Years 4 MonthsCurrent
Neelakantan Sujaya BabuDirector10 Jun 200521 Years 4 MonthsCurrent

Peer comparison

Nutragen Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vivatest Lifescience Private Limited₹2.28 Cr (FY 2024)126.0%Mumbai, Maharashtra, India
Biopin-Aambal Life Sciences Private Limited₹2.26 Cr (FY 2025)41.0%Vadodara, Gujarat, India
Nutragen Pharma Private Limitedthis company₹2.21 Cr (FY 2023)₹1.34 Lakh0.6%9.0%Chennai, Tamil Nadu, India
Belicia Lifesciences Private Limited₹2.17 Cr (FY 2024)-6.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Nutragen Pharma Private Limited, buy the company report.

Auditor

Nutragen Pharma Private Limited is audited by RAVI AND SABIN for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RAVI AND SABINFY 20230006883S

Shareholding

The shareholding of Nutragen Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nutragen Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.84 Cr
Satisfied charges
₹1.49 Cr
Breakdown by lending institutions
Others₹1.40 Cr
The South Indian Bank Limited₹0.44 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Mar 2025101114236Others₹1.4 CrOpen
30 Sep 2021100493891The South Indian Bank Limited₹44 LakhOpen
21 Dec 200610053854State Bank of Travancore₹1.49 CrSatisfied

To see the full charge records of Nutragen Pharma Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nutragen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Nutragen Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
32AACCN4110B1ZFKeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Nutragen Pharma Private Limited, buy the company report.

Recent activity

Nutragen Pharma Private Limited has 7 board changes on record since 2005: 3 appointments and 4 cessations. The latest: Padmini Sankaran ceased to be Additional Director on 27 Mar 2009.

AGM
Nutragen Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 1.40 Cr registered on 15 Mar 2025 with Charge ID 101114236 was modified on 27 Aug 2025.
Filing
Nutragen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101114236 was registered on 15 Mar 2025.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 0.44 Cr with Charge ID 100493891 was registered on 30 Sep 2021.
Charges
A charge registered on 21 Dec 2006 via Charge ID 10053854 with State Bank Of Travancore was fully satisfied on 01 Nov 2019.
Charges
A charge with State Bank Of Travancore of Rs. 1.49 Cr registered on 21 Dec 2006 with Charge ID 10053854 was modified on 10 Mar 2010.
Ceased
Padmini Sankaran ceased to be Additional Director.
Ceased
Achamma Oomman ceased to be Director.
Ceased
Cherian Oomman Koillenmareth ceased to be Managing Director.
Appointed
Padmini Sankaran was appointed as Director.
Ceased
Sujayababu Jayasankar ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Nutragen Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 June 2005 (21+ years old) and is registered under CIN U24232TN2005PTC056577.

Nutragen Pharma has 3 current directors:

The latest financial statements of Nutragen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nutragen Pharma is 32AACCN4110B1ZF, registered in Kerala. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Nutragen Pharma is U24232TN2005PTC056577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nutragen Pharma has 4 court cases on record: 4 filed against it. 1 is pending. Most are in the district courts.

Nutragen Pharma was incorporated on 10 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Nutragen Pharma by revenue are Vivatest Lifescience Private Limited, Biopin-Aambal Life Sciences Private Limited, Belicia Lifesciences Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (wholesale trading).

Padmini Sankaran ceased to be Additional Director on 27 Mar 2009. Achamma Oomman ceased to be Director on 16 Jan 2009. Cherian Oomman Koillenmareth ceased to be Managing Director on 16 Jan 2009. Nutragen Pharma has 7 board changes on record in total.

Yes, Nutragen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-12-0016426).

Nutragen Pharma can be reached through the website nutragenpharma.in. Its registered office is in Chennai, Tamil Nadu, India.